Sofinnova Investments, Inc. Chinook Therapeutics, Inc. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$21.53 - $26.8 $4.22 Million - $5.25 Million	195,889 Added 24.29%	1,002,348 $23.2 Million
Q4 2022 Feb 13, 2023	BUY	$18.63 - $27.35 $9.66 Million - $14.2 Million	518,558 Added 180.12%	806,459 $21.1 Million
Q3 2022 Nov 08, 2022	BUY	$17.51 - $23.37 $197,722 - $263,894	11,292 Added 4.08%	287,901 $5.66 Million
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $3.48 Million - $5.2 Million	276,609 New	276,609 $4.84 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.